Novel treatment options for juvenile idiopathic arthritis

Katherine A. Steigerwald; Norman T. Ilowite

doi:10.1586/17512433.2015.1061428

Novel treatment options for juvenile idiopathic arthritis

Katherine A. Steigerwald, Norman T. Ilowite

Pediatrics

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.

Original language	English (US)
Pages (from-to)	559-573
Number of pages	15
Journal	Expert Review of Clinical Pharmacology
Volume	8
Issue number	5
DOIs	https://doi.org/10.1586/17512433.2015.1061428
State	Published - Sep 3 2015

Keywords

Biologics
Juvenile idiopathic arthritis
Novel
Small molecules
Treatment

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics
Pharmacology (medical)

Access to Document

10.1586/17512433.2015.1061428

Cite this

@article{b76fe74fc12a46de9de869909b1a7b9f,

title = "Novel treatment options for juvenile idiopathic arthritis",

abstract = "The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.",

keywords = "Biologics, Juvenile idiopathic arthritis, Novel, Small molecules, Treatment",

author = "Steigerwald, {Katherine A.} and Ilowite, {Norman T.}",

note = "Publisher Copyright: {\textcopyright} 2015 {\textcopyright} Informa UK, Ltd.",

year = "2015",

month = sep,

day = "3",

doi = "10.1586/17512433.2015.1061428",

language = "English (US)",

volume = "8",

pages = "559--573",

journal = "Expert Review of Clinical Pharmacology",

issn = "1751-2433",

publisher = "Expert Reviews Ltd.",

number = "5",

}

TY - JOUR

T1 - Novel treatment options for juvenile idiopathic arthritis

AU - Steigerwald, Katherine A.

AU - Ilowite, Norman T.

PY - 2015/9/3

Y1 - 2015/9/3

N2 - The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.

AB - The purpose of this review is to summarize the newer and possible future treatments for the arthritis and systemic features in children with juvenile idiopathic arthritis (JIA), including evidence supporting their efficacy and safety.

KW - Biologics

KW - Juvenile idiopathic arthritis

KW - Novel

KW - Small molecules

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84939785375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939785375&partnerID=8YFLogxK

U2 - 10.1586/17512433.2015.1061428

DO - 10.1586/17512433.2015.1061428

M3 - Review article

C2 - 26294075

AN - SCOPUS:84939785375

SN - 1751-2433

VL - 8

SP - 559

EP - 573

JO - Expert Review of Clinical Pharmacology

JF - Expert Review of Clinical Pharmacology

IS - 5

ER -

Novel treatment options for juvenile idiopathic arthritis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this